22186-1 |
Chlamydia sp Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia sp IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22186-1 |
|
|
|
|
Both |
|
|
|
0 |
Chlamydia IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chlam; Chlamid; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; species; spp; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22187-9 |
Chlamydia trachomatis Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22187-9 |
|
|
|
|
Both |
|
|
|
0 |
C trach Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22188-7 |
Chlamydia trachomatis Ab.IgA |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22188-7 |
|
|
|
|
Both |
|
|
|
0 |
C trach IgA Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C tracho; C trachomatis; Cerebral spinal fluid; Cerebrospinal Fl; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22189-5 |
Chlamydia trachomatis Ab.IgA |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis IgA Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22189-5 |
|
|
|
|
Both |
|
|
|
0 |
C trach IgA Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
2219-4 |
Dopamine beta-hydroxylase |
CCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2219-4 |
|
|
|
|
Both |
|
|
|
0 |
Dopamine B-Hydroxylae SerPl-cCnc |
|
|
|
Y |
|
B; Catalytic Concentration; Chemistry; DBH; Dopamine beta-monooxygenase; Dopamine B-Hydroxylae; Hydroxyl; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.69 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
Release 2.69: COMPONENT: Removed TALLMAN lettering because the Component does not primarily represent the tall man drug; |
0 |
22190-3 |
Chlamydia trachomatis Ab.IgG |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22190-3 |
|
|
|
|
Both |
|
|
|
0 |
C trach IgG CSF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C trac; C trach; C tracho; C trachomatis; Cerebral spinal fluid; Cerebrospinal Fl; Chlam; Chlam trac; Chlamid; CT; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Trachoma |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22191-1 |
Chlamydia trachomatis Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22191-1 |
|
|
|
|
Both |
|
|
|
0 |
C trach IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22192-9 |
Chlamydia trachomatis Ab.IgM |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22192-9 |
|
|
|
|
Both |
|
|
|
0 |
C trach IgM CSF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C trac; C trach; C tracho; C trachomatis; Cerebral spinal fluid; Cerebrospinal Fl; Chlam; Chlam trac; Chlamid; CT; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Trachoma |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22193-7 |
Chlamydia trachomatis Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22193-7 |
|
|
|
|
Both |
|
|
|
0 |
C trach IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22194-5 |
Chlamydia trachomatis B Ab.IgA |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis B IgA Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22194-5 |
|
|
|
|
Both |
|
|
|
0 |
C trach B IgA Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach B; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type B; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22195-2 |
Chlamydia trachomatis B Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis B IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22195-2 |
|
|
|
|
Both |
|
|
|
0 |
C trach B IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach B; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type B; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22196-0 |
Chlamydia trachomatis B Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis B IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22196-0 |
|
|
|
|
Both |
|
|
|
0 |
C trach B IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach B; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type B; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22197-8 |
Chlamydia trachomatis C Ab.IgA |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis C IgA Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22197-8 |
|
|
|
|
Both |
|
|
|
0 |
C trach C IgA Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach C; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type C; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Rh Blood Group System; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22198-6 |
Chlamydia trachomatis C Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis C IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22198-6 |
|
|
|
|
Both |
|
|
|
0 |
C trach C IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach C; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type C; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Rh Blood Group System; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22199-4 |
Chlamydia trachomatis C Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis C IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22199-4 |
|
|
|
|
Both |
|
|
|
0 |
C trach C IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach C; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type C; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Rh Blood Group System; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
222-0 |
Dicloxacillin |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Dicloxacillin [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
222-0 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Dicloxacillin Islt KB |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Dynapen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Pathocil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Veracillin; Veracilline |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
2220-2 |
Elastase.pancreatic.free |
CCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Elastase.pancreatic Free [Enzymatic activity/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2220-2 |
|
|
|
|
Both |
|
|
|
0 |
Elastase Panc Free Ser-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; ELA; Elastase Panc; Elastase Panc Free; FR; Non-protein bound; Pancr; Pancreatc; Pancreatic elastase 1; Pancreatic elastase I; Pancreatopeptidase E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
22200-0 |
Chlamydia trachomatis G+F+K Ab.IgA |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22200-0 |
|
|
|
|
Both |
|
|
|
0 |
C trach G+F+K IgA Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach G+F+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type G+F+K; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Intermediate; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22201-8 |
Chlamydia trachomatis G+F+K Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22201-8 |
|
|
|
|
Both |
|
|
|
0 |
C trach G+F+K IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach G+F+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type G+F+K; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Intermediate; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22202-6 |
Chlamydia trachomatis G+F+K Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22202-6 |
|
|
|
|
Both |
|
|
|
0 |
C trach G+F+K IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach G+F+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type G+F+K; CT; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Intermediate; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22203-4 |
Clostridium tetani Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
DISCOURAGED |
Clostridium tetani IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
MICRO |
|
22203-4 |
|
|
|
|
Both |
|
|
|
0 |
C tetani IgG Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C tetani; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tet; Tetanus; UniversalLabOrders |
2.73 |
1.0n |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
22204-2 |
Coccidioides immitis Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22204-2 |
|
|
|
|
Both |
|
|
|
0 |
C immitis Ab CSF Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Cerebral spinal fluid; Cerebrospinal Fl; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T proteolyticum; Trichosporon proteolyticum; Valley fever |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22205-9 |
Coccidioides immitis Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Coccidioides immitis Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22205-9 |
|
|
|
|
Both |
|
|
|
0 |
C immitis Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Serum; SR; T proteolyticum; Trichosporon proteolyticum; Valley fever |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22206-7 |
Coccidioides immitis Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Coccidioides immitis Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22206-7 |
|
|
|
|
Both |
|
|
|
0 |
C immitis Ab Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Infectious Disease; InfectiousDisease; Microbiology; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; Serum; SR; T proteolyticum; Trichosporon proteolyticum; Valley fever |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22207-5 |
Coccidioides immitis Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coccidioides immitis Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22207-5 |
|
|
|
|
Both |
|
|
|
0 |
C immitis Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Cerebral spinal fluid; Cerebrospinal Fl; Coccidioides esteriformis; Coccidiomycosis; Coccio; Dilution factor; Dilution Factor (Titer); G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; Random; San Joaquin Valley fever; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T proteolyticum; Titer; Titered; Titre; Trichosporon proteolyticum; Ttr; Valley fever |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |